AbbVie
ABBV
#25
Rank
$370.74 B
Marketcap
$210.01
Share price
-0.92%
Change (1 day)
17.63%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of December 2024 : $3.36 Billion USD

According to AbbVie's latest financial reports the company has $3.36 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$$3.36 B-67.64%
2023-12-31$$10.39 B-39.86%
2022-12-31$$17.28 B11.99%
2021-12-31$$15.43 B17.86%
2020-12-31$$13.09 B-260.27%
2019-12-31$-$8.18 Billion-3.24%
2018-12-31$-$8.45 Billion-265.71%
2017-12-31$$5.09 B9.94%
2016-12-31$$4.63 B17.52%
2015-12-31$$3.94 B126.46%
2014-12-31$$1.74 B-61.22%
2013-12-31$$4.49 B33.57%
2012-12-31$$3.36 B-71.82%
2011-12-31$$11.93 B-24.01%
2010-12-31$$15.70 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$88.49 B 2,530.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.38 B 387.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.27 B 324.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.87 B 74.70%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.24 B 472.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.71 B 396.91%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.42 B 388.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
$40.87 B 1,114.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.58 B-23.02%๐Ÿ‡บ๐Ÿ‡ธ USA